- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Mesothelioma or non-small cell lung cancer
- Meeting Date: March 2023
- Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 307KB)
- Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 38KB)
Pemetrexed – March 2023
Pemetrexed: Solution concentrate for I.V. infusion 100 mg in 4 mL vial, Solution concentrate for I.V. infusion 500 mg in 20 mL vial, Solution concentrate for I.V. infusion 1000 mg in 40 mL vial; Pemetrexed EVER Pharma
Last updated
30 June 2023